Mark Wood is VP & Human Resources at BIOMARIN PHARMACEUTICAL INC (BMRN). They have made 29 open-market trades across 1 company since 2007, most recently 2013-05-22.
CIK 0001401782
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 29 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BMRN | 20,277 | $1.1M |
Shares reported on the most recent Form 4, priced at the 2013-05-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BMRN | SELL · 10b5-1 | 2013-05-22 | 2013-05-23 | $67.12 | $208K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2013-04-22 | 2013-04-23 | $65.57 | $203K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2013-03-22 | 2013-03-26 | $60.21 | $187K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2013-02-22 | 2013-02-26 | $55.22 | $171K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2013-01-22 | 2013-01-24 | $54.99 | $2.6M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-12-13 | 2012-12-17 | $49.17 | $512K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-11-23 | 2012-11-26 | $48.92 | $130K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-10-22 | 2012-10-24 | $41.86 | $112K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-09-24 | 2012-09-26 | $40.48 | $108K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-08-22 | 2012-08-24 | $37.93 | $101K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-07-23 | 2012-07-25 | $39.25 | $105K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-06-27 | 2012-06-29 | $38.00 | $31K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-06-22 | 2012-06-26 | $36.83 | $68K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-05-22 | 2012-05-24 | $38.01 | $101K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-05-11 | 2012-05-15 | $38.00 | $93K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-04-23 | 2012-04-25 | $34.54 | $64K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-03-22 | 2012-03-26 | $35.65 | $66K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-02-22 | 2012-02-23 | $35.14 | $65K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-02-02 | 2012-02-06 | $38.00 | $247K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-01-23 | 2012-01-24 | $34.96 | $65K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2011-12-22 | 2011-12-23 | $33.79 | $63K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2011-11-22 | 2011-11-25 | $32.18 | $60K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2011-10-24 | 2011-10-26 | $33.32 | $62K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2011-09-22 | 2011-09-26 | $29.92 | $55K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2011-08-31 | 2011-09-01 | $30.00 | $25K | -18.2% | +2.1% | +2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.